XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
OPERATING ACTIVITIES      
Net income including non-controlling interests $ 11,886 $ 3,338  
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:      
Depreciation and amortization 2,681 2,607  
Provision for credit losses 1,200 1,361  
Equity-based awards compensation expense 1,651 1,886  
Deferred income taxes 2,181 (1,369)  
Gain on sale of partnership interest 96 0  
Derecognition (write-off) of goodwill - closed clinics 0 1,859 $ 1,859
Other 0 129  
Changes in operating assets and liabilities:      
(Increase) decrease in patient accounts receivable (4,688) 3,209  
Decrease (increase) in accounts receivable - other 220 (1,752)  
Decrease in other assets 221 2,846  
Increase in accounts payable and accrued expenses 3,969 2,027  
Increase in other long-term liabilities (1,743) 239  
Net cash provided by operating activities 17,674 16,380  
INVESTING ACTIVITIES      
Purchase of fixed assets (1,608) (2,754)  
Purchase of majority interest in businesses, net of cash acquired (11,747) (11,633)  
Purchase of redeemable non-controlling interest - temporary equity 0 (1,852)  
Proceeds on sales of partnership interest and clinics 152 316  
Net cash used in investing activities (13,203) (15,923)  
FINANCING ACTIVITIES      
Distributions to non-controlling interests, permanent and temporary equity (5,265) (2,341)  
Proceeds from revolving line of credit 60,000 88,000  
Payments on revolving line of credit (60,000) (20,000)  
Principal payments on notes payable (145) (114)  
Payment of medicare accelerated and advance funds (14,054) 0  
Other 12 1  
Net cash (used in) provided by financing activities (19,452) 65,546  
Net (decrease) increase in cash and cash equivalents (14,981) 66,003  
Cash and cash equivalents - beginning of period 32,918 23,548 23,548
Cash and cash equivalents - end of period 17,937 89,551 $ 32,918
Cash paid during the period for:      
Income taxes 62 242  
Interest 298 349  
Non-cash investing and financing transactions during the period:      
Purchase of businesses - seller financing portion 300 300  
Payable related to purchase of redeemable non-controlling interest, temporary equity 4,829 0  
Notes receivable related to sale of partnership interest - redeemable non-controlling interest 287 0  
Dividends payable to USPH shareholders $ 4,514 $ 4,110